ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting - Associated Press

Submitted by Anonymous (not verified) on Sat, 05/18/2019 - 15:36

ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting  Associated PressPress release *content* from Business Wire. The AP news staff was not involved in its creation.